enGene Therapeutics（ENGN.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

风投/私募40.52%
机构投资者33.09%
公众及其他15.77%
对冲基金9.96%
个人与内部人士0.66%

主要股东

主要股东最新
股东
Forbion Capital Partners B.V.	14.38%	963.26 万	0.00%	+0	2026/06/30
BML Capital Management, LLC	9.96%	666.99 万	--	+666.99 万	2026/06/30
Artal Group S.A.	8.18%	548.20 万	0.34%	+22.88 万	2026/06/30
Perceptive Advisors LLC	7.20%	482.22 万	1.50%	-100.53 万	2026/06/30
Lumira Capital Investment Management Inc.	5.75%	384.93 万	0.00%	+0	2026/04/24
Acorn Bioventures	5.01%	335.73 万	3.11%	+208.60 万	2026/07/20
Columbia Management Investment Advisers, LLC	3.99%	267.59 万	--	+267.59 万	2026/06/30
Nextech Invest Ltd.	3.47%	232.49 万	0.00%	+0	2026/06/30
ADAR1 Capital Management, LLC	3.14%	210.50 万	2.94%	+197.13 万	2026/06/30
Vestal Point Capital, LP	2.49%	166.74 万	0.74%	-49.76 万	2026/06/30
Peapod Lane Capital LLC	1.65%	110.21 万	--	+110.21 万	2026/06/30
Balyasny Asset Management L.P.	1.50%	100.73 万	0.21%	-14.17 万	2026/06/30
Millennium Management LLC	1.44%	96.66 万	0.01%	+6,946.00	2026/06/30
Omega Fund Management, LLC	1.31%	87.64 万	0.00%	+0	2026/06/30
Renaissance Technologies LLC	1.24%	82.97 万	1.01%	+67.36 万	2026/06/30
Invus Financial Advisors, LLC	1.16%	77.47 万	0.05%	+3.47 万	2026/06/30
SR One Capital Management, LP	1.12%	74.78 万	0.00%	+0	2026/06/30
Citadel Advisors LLC	1.07%	71.77 万	0.84%	+56.37 万	2026/06/30
Affinity Asset Advisors, LLC	0.90%	60.00 万	0.02%	-1.04 万	2026/06/30
UBS Asset Management AG	0.76%	50.91 万	0.74%	+49.61 万	2026/06/30